Sweetch Adds Global Digital and Remote Health Trailblazer Prof. Joseph Kvedar as New Advisory Board Member

Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced today that Prof. Joseph Kvedar has joined its advisory board. Prof. Kvedar brings a deep understanding of remote health, digital therapeutics, and reimbursement to Sweetch, and will focus on accelerating the commercial rollout and demonstrated positive clinical impact of the […]

READ MORE 12 October 2021

Sweetch Enters Strategic Partnership with Grupo Fleury’s Saúde iD to Tackle Brazil’s Chronic Disease Prevalence Amidst COVID-19 Pandemic

Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced a partnership with Grupo Fleury, one of Brazil’s leading healthcare providers. Fleury will implement Sweetch as part of the company’s Saúde iD telemedicine services to improve health care outcomes for patients living with chronic conditions as part of a substantial multi-year contract.

READ MORE 22 September 2021

Sweetch raises $20M for a personalized engagement system designed to boost health outcomes

Yossi Bahagon, the founder of Sweetch, describes the company’s approach to digital reminders as a mixture of artificial intelligence and emotional intelligence. The app will use AI to analyse “lifeprint” data picked up through a smartphone. Then it delivers messages to when you might be more likely to respond to them and in a “tone […]

READ MORE 19 July 2021

Top 10 Post-Covid Tech Trends

Onsite diagnostic testing, online medical visits, and remote monitoring are just the beginning of healthcare moving into the 21st century, giving a whole new meaning to the term “digital transformation.” Startups driving this transformation include […] Sweetch, a clinically validated disease management optimization platform.

READ MORE 13 July 2021

Sweetch Partners with Bayer G4A as one of their Agents of Change for 2020 – Interview

Meet our G4A 2020 Partner, Sweetch! Yossi Bahagon, Founder & CEO, talks to Jessica DaMassa of WTF Health about his company’s role in the transformation of healthcare.

READ MORE 15 January 2021

Bayer initiates new G4A Digital Health Partnerships Program

Bayer will support five new startup companies as part of the company’s G4A Digital Health Partnerships Program. Focus will be on fostering the development of a digital health ecosystem, while driving forward integrated healthcare solutions in the fields of cardiometabolic and renal diseases, oncology, and women’s health.

READ MORE November 18, 2020

AI In Healthcare Use Case #30: Sweetch

Founded in 2014, Sweetch is a clinically validated mobile-health platform that utilizes artificial technology (AI) to significantly increase patients’ engagement and compliance with essential health promotion and chronic disease management recommendations through Just-in-Time Adaptive Intervention.

READ MORE July 16, 2019

Prof. David Nash Appointed to Sweetch Advisory Board

Sweetch Health, an Artificial Intelligence based platform for prediction, prevention and management of chronic diseases, has announced that healthcare pioneer Prof. David Nash, MD, MBA, Founding Dean Emeritus of the Jefferson College of Population Health has joined the Sweetch Advisory Board.

READ MORE June 27, 2019

IQVIA, EMIS Health partner to support GPs in England electronically ‘prescribe’ apps to patients

This morning, data science company IQVIA unveiled a partnership with EMIS Health, a Leeds-based primary care software provider, to enable GPs in England electronically ‘prescribe’ apps evaluated against NHS standards to patients.

READ MORE June 19, 2019

Sweetch: Promising Patients’ Compliance and Engagement with AI-based Behavioral Intelligence Engine

Artificial Intelligence (AI) is finding its way in various industries and uplifting their service capabilities to a great extent. The healthcare industry is no exception to this.

READ MORE May 5, 2019